You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR ORABASE HCA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ORABASE HCA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02329600 ↗ Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus Completed Cairo University Phase 3 2013-06-01 The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.
NCT02645656 ↗ Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) Unknown status SVS Institute of Dental Sciences Phase 2 2013-12-01 Curcumin (diferuloylmethane) is the chief component of the spice turmeric and is derived from the rhizome of the East Indian plant Curcuma longa. Curcuma longais a member of the Zingiberacae (ginger) family of botanicals and is a perennial plant that is native to Southeast Asia. Turmeric contains a class of compounds known as the curcuminoids, comprised of curcumin, demethoxy curcumin and bisdemethoxycurcumin.
NCT03026478 ↗ Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus Unknown status Garlapati Komali Phase 2 2016-05-06 Oral Lichen Planus (OLP) is an autoimmune, chronic inflammatory mucocutaneous disease characterized by pain and burning sensation. The major types of OLP are the following: reticular, atrophic, erosive-ulcerative, bullous and pigmentous form.Its etiology remains unclear. The presence of auto-cytotoxic T cell clones in the lesions suggests the role of autoimmunity. Numerous treatment options of OLP include topical and systemic agents depending on severity of lesions . Topical corticosteroids abide the mainstay of therapy,and are widely accepted as the primary treatment of choice.Hence this study is designed to evaluate and compare the clinical efficacy of topical Clobetasol 0.05% in orabase and Betamethasone 0.05% in orabase in combination with Clotrimazole 1% in the management of symptomatic Oral Lichen Planus.
NCT03415165 ↗ Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus Unknown status Cairo University Early Phase 1 2018-01-03 Is topical application of green tea polyphenols buccal tablet more effective in treatment of patients with symptomatic oral lichen planus in comparison with topical application of corticosteroids and what is the most effective concentration of polyphenols
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ORABASE HCA

Condition Name

Condition Name for ORABASE HCA
Intervention Trials
Oral Lichen Planus 7
Oral Ulcer Due to Pemphius Vularis 1
Oral Ulcer Due to Steven Johnson's Syndrome 1
Autoimmune 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ORABASE HCA
Intervention Trials
Lichen Planus, Oral 7
Lichen Planus 7
Oral Ulcer 2
Behcet Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ORABASE HCA

Trials by Country

Trials by Country for ORABASE HCA
Location Trials
Egypt 4
India 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ORABASE HCA

Clinical Trial Phase

Clinical Trial Phase for ORABASE HCA
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ORABASE HCA
Clinical Trial Phase Trials
Unknown status 5
Completed 4
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ORABASE HCA

Sponsor Name

Sponsor Name for ORABASE HCA
Sponsor Trials
Cairo University 5
Sherine Adel Nasry 1
Mona Taha Mohammed MD 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ORABASE HCA
Sponsor Trials
Other 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.